2.4 mg semaglutide Wegovy mg/0.75 mL pre-filled pen-injector Images 1 in the body Dosing Schedule | Wegovy® (semaglutide)

A 250 mcg dose requires 1.25 mL, which exceeds the capacity of a standard 1 mL insulin syringe

The stomach area offers the largest surface area of any approved injection site, which means more room for rotation and less chance of hitting the same spot twice

Fiber and protein can mimic some effects of GLP-1s

Patients who are desperate to start or continue their treatment might not follow the recommended step-up approach, increasing their risk of severe side effects

Patients with severe ARPKD and onset during infancy or early childhood have a mortality rate of up to 40% and typically present with respiratory failure and progressive renal impairment

Not a Standalone Solution: Semaglutide is most effective when combined with diet and exercise